Showing results (81-90 of 648) with videos related to
Sort By:
Pageof 65
Open Heart|September 5, 2015
Ischaemia change with revascularisation versus medical therapy in reduced ejection fractionRobert J Mentz, Mona Fiuzat, Linda K Shaw, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 20, 2015
Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imagingAfshin Farzaneh-Far, Linda K Shaw, Allison Dunning, et al.The American Journal of Cardiology|January 11, 2003
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failureWendy A Gattis, Christopher M O'Connor, Jeffrey D Leimberger, et al.Journal of the American College of Cardiology|September 25, 2010
Troponin elevation in heart failure prevalence, mechanisms, and clinical implicationsRobb D Kociol, Peter S Pang, Mihai Gheorghiade, et al.The American Journal of Cardiology|February 8, 2011
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study)Wei Jiang, Ranga Krishnan, Maragatha Kuchibhatla, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2012
Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritisFrederick Wolfe, Marcy B Bolster, Christopher M O'Connor, et al.European Journal of Heart Failure|June 30, 2011
Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registryRyenn West, Li Liang, Gregg C Fonarow, et al.JAMA|October 6, 2005
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trialsMonica R Shah, Vic Hasselblad, Lynne W Stevenson, et al.American Heart Journal|October 3, 2002
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4)Christopher M O'Connor, Wendy A Gattis, Kirkwood F Adams, et al.European Journal of Heart Failure|February 4, 2012
Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HFRobert J Mentz, Mona Fiuzat, Daniel M Wojdyla, et al.Pageof 65